Wealthfront’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1.62M Buy
8,493
+2,736
+48% +$503K 0.02% 160
2018
Q2
$960K Sell
5,757
-1,724
-23% -$277K 0.01% 257
2018
Q1
$1.26M Buy
7,481
+4,575
+157% +$767K 0.01% 210
2017
Q4
$475K Sell
2,906
-1,817
-38% -$326K 0.01% 364
2017
Q3
$968K Sell
4,723
-6,023
-56% -$1.4M 0.01% 202
2017
Q2
$2.61M Buy
10,746
+1,598
+17% +$376K 0.04% 75
2017
Q1
$2.19M Buy
9,148
+4,255
+87% +$991K 0.04% 79
2016
Q4
$1.03M Buy
4,893
+468
+11% +$97K 0.02% 114
2016
Q3
$1.02M Buy
4,425
+531
+14% +$130K 0.02% 101
2016
Q2
$900K Buy
3,894
+117
+3% +$27K 0.02% 106
2016
Q1
$1.01M Sell
3,777
-1,078
-22% -$309K 0.03% 86
2015
Q4
$1.52M Buy
4,855
+1,374
+39% +$409K 0.05% 65
2015
Q3
$946K Buy
3,481
+1,233
+55% +$379K 0.04% 82
2015
Q2
$682K Buy
2,248
+48
+2% +$14.3K 0.03% 82
2015
Q1
$655K Buy
2,200
+469
+27% +$134K 0.03% 65
2014
Q4
$446K Buy
1,731
+321
+23% +$80.2K 0.03% 80
2014
Q3
$340K Buy
1,410
+513
+57% +$115K 0.02% 83
2014
Q2
$199K Buy
897
+386
+76% +$79.9K 0.02% 110
2014
Q1
$107K Buy
+511
New +$101K 0.01% 124

Other funds holding AGN

Wealthfront's AGN Position: Q3 2018 in Review

Wealthfront increased its Allergan plc (AGN) stake by 48% in Q3 2018, buying an estimated $503K and bringing the position to 8,493 shares worth $1.62M. The position accounts for 0.02% of the portfolio, ranked #160.

Wealthfront first reported a position in AGN in Q1 2014 and has held it in 19 quarters since. The position peaked at $2.61M in Q2 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Wealthfront held 8,493 shares of Allergan plc worth $1.62M as of Q3 2018.
  • Wealthfront bought 2,736 Allergan plc shares in Q3 2018, an estimated $503K.
  • Allergan plc made up 0.02% of Wealthfront's portfolio in Q3 2018, its #160 holding.
  • Wealthfront first reported a position in Allergan plc in Q1 2014 and has held it in 19 quarters since.
  • Wealthfront's Allergan plc position peaked at $2.61M in Q2 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.